MEI Pharma, Inc. (LITS) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MEI Pharma, Inc. (LITS:NASDAQ), powered by AI.
- Current Price
- $0.92
- P/E Ratio
- -0.4
- Market Cap
- 6M
- Sector
- Healthcare
What is the MEI Pharma, Inc. stock price forecast?
MEI Pharma, Inc. is currently trading at $0.92. View real-time AI analysis on Alpha Lenz.
What is MEI Pharma, Inc. insider trading activity?
View the latest insider trading data for MEI Pharma, Inc. on Alpha Lenz.
What is MEI Pharma, Inc.'s P/E ratio?
MEI Pharma, Inc.'s P/E ratio is -0.4.
MEI Pharma, Inc.
NASDAQ · LITS“MEI Pharma, Inc. trades at a P/E of -0.4 (undervalued) with modest ROE of -63.8%.”
Ask for details →Company Overview
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“MEI Pharma, Inc. trades at a P/E of -0.4 (undervalued) with modest ROE of -63.8%.”
Ask for details →Frequently Asked Questions
MEI Pharma, Inc. (ticker: LITS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 4 employees. Market cap is $6M.
The current price is $0.92 with a P/E ratio of -0.38x and P/B of 0.36x.
ROE is -63.84%.